Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - NET CHANGE IN CASH
Net Change in Cash IKT - Inhibikase Therapeutics, Inc.
1.98 M
LAST VALUE
-72.84%
2 YEAR CAGR
40.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR